CYCN (Cyclerion Therapeutics, Inc. Common Stock) Stock Analysis - Community
Cyclerion Therapeutics, Inc. Common Stock (CYCN) is a publicly traded Healthcare sector company. As of May 21, 2026, CYCN trades at $3.02 with a market cap of $13.08M and a P/E ratio of -2.27. CYCN moved +4.33% today. Year to date, CYCN is +123.19%; over the trailing twelve months it is -6.21%. Its 52-week range spans $1.03 to $9.47. Rallies surfaces CYCN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade CYCN?
Rallies community data for CYCN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Slate Path Capital LP sold 357.88K (~$555.11K) on Nov 21, 2024.
MCGUIRE TERRANCE sold 8 (~$27.16) on Aug 9, 2023.
MCGUIRE TERRANCE bought 92.83K (~$289.63K) on Jun 3, 2021.
CYCN Analyst Consensus
CYCN analyst coverage data. Average price target: $0.00.
Common questions about CYCN
How does the Rallies community trade CYCN?
Rallies community data for CYCN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for CYCN?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for CYCN when enough community data is available.
Is CYCN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CYCN. It does not provide personalized investment advice.